Shigeru Fujimoto

Title: Shigeru Fujimoto: Innovator in Biochemical Research

Introduction

Shigeru Fujimoto is a notable inventor based in Ikeda, Japan. He has made significant contributions to the field of biochemical research, particularly in the development of monoclonal antibodies and methods for producing physiologically active proteins. With a total of 4 patents to his name, Fujimoto's work has had a substantial impact on various applications in the industry.

Latest Patents

Fujimoto's latest patents include a groundbreaking invention related to monoclonal antibodies for immunoassays of detergents and their degradation products. This patent describes a hybridoma that is created by fusing a spleen cell or lymphocyte from an animal immunized with a surfactant compound and protein with a myeloma cell. The resulting hybridoma produces a monoclonal antibody against the surfactant compound or its degradation product. Additionally, he has developed a method for producing interleukin-2, which enhances the yield of physiologically active proteins by cultivating Escherichia coli with specific nutrient sources.

Career Highlights

Fujimoto is currently associated with Takeda Chemical Industries, Inc., where he continues to advance his research and innovations. His work has been instrumental in improving methods for producing essential biochemical compounds, which are crucial for various medical and industrial applications.

Collaborations

Fujimoto has collaborated with esteemed colleagues such as Kazuaki Kitano and Yukio Toyoda. These partnerships have fostered a collaborative environment that enhances the quality and scope of their research endeavors.

Conclusion

Shigeru Fujimoto's contributions to biochemical research through his patents and collaborations highlight his role as an influential inventor in the field. His innovative approaches continue to pave the way for advancements in immunoassays and protein production.